妊娠期妇女用药风险评估案例分析  

Case Analysis of Drug Use Risk Evaluation in Pregnancy Women

作　　者：杨智 易燕桃 蒙晓彤 YANG Zhi;YI Yan-tao;MENG Xiao-tong(The Second People's Hospital of Zhaoqing,Zhaoqing 526060,China)

机构地区：[1]肇庆市第二人民医院,筆庆526060

出　　处：《中国合理用药探索》2022年第2期36-40,共5页Chinese Journal of Rational Drug Use

摘　　要：目的:总结临床药师对妊娠期妇女用药案例分析和建议,为妊娠期妇女合理用药提供资料参考。方法:选取本院2018~2019年妊娠期妇女的5个用药资料作为案例,结合妊娠期用药风险评估依据进行讨论分析。结果:临床药师对妊娠期妇女用药风险的判断中,最重要一点是必须掌握服用药物的胎龄,其次是根据资料评估药物风险性,最后结合患者自身情况、合并疾病等因素,提供合理用药建议。结论:临床药师对妊娠期妇女的用药风险评估有利于推动临床药师向更专业化的方向发展,为妊娠妇女提供充分的安全用药证据支持。Objective:To summarize the case analysis and suggestions of clinical pharmacists on drug use in pregnant women,and provides references for rational drug use in pregnant women.Methods:The data of 5 medication cases of pregnant women in our hospital from 2018 to 2019 were selected respectively,and combined with the basis for risk assessment of medication during pregnancy to discuss and analyze.Results:The most important point for clinical pharmacists to judge the risk of medication in pregnant women is that they must grasp the gestational age of taking drugs,followed by assessing the risk of drugs according to the data,and finally providing reasonable medication suggestions based on the patient’s own situation,combined diseases and other factors.Conclusion:The drug use risk evaluation in pregnancy women by clinical pharmacist is beneficial to promote the development of clinical pharmacists towards a more professional direction and to provide sufficient evidence support for safe medication for pregnant women.

关 键 词：临床药师 妊娠期 安全用药 风险评估 药物 

分 类 号：R969.3[医药卫生—药理学]